Trials / Unknown
UnknownNCT06169358
Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 627 (estimated)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to understand the epidemiological status of Fabry in patients with hypertrophic cardiomyopathy or left ventricular hypertrophy through multi-center early identification of high-risk patients in cardiology according to high-risk profiles, supplemented by DBS (dried blood disc) screening tools, and to explore the screening and diagnosis methods of patients with Fabry disease in cardiology, so as to promote the early identification, diagnosis and treatment of Fabry in cardiology.
Conditions
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2023-12-13
- Last updated
- 2023-12-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06169358. Inclusion in this directory is not an endorsement.